Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

Cites (296)

Items 201–296 of 296

1. Homeostatic control of membrane fatty acid composition in the rat after dietary lipid treatment
   Robert Alan Gibson, Edward J. McMurchie, J.S. Charnock, G. M. Kneebone · 1984 · Lipids
2. Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo
   Boris Ferger, Christopher Spratt, C. D. Earl, Peter Teismann, Wolfgang H. Oertel, Klaus Kuschinsky · 1998 · Naunyn-Schmiedeberg s Archives of Pharmacology
3. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study
   Jesús Ramírez‐Bermúdez · 2003 · Schizophrenia Research
4. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study
   Macheri S. Keshavan, Jeffrey A. Stanley, Debra M. Montrose, Nancy J. Minshew, Jay W. Pettegrew · 2003 · Molecular Psychiatry
5. Nitric oxide synthase (NOS) in schizophrenia
   Craig N. Karson, W. Sue T. Griffin, Robert Emil Mrak, Mohammed Husain, Ted M. Dawson, Solomon H. Snyder, Norman C. Moore, William Q. Sturner · 1996 · Molecular and Chemical Neuropathology
6. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients
   Xiangyang Zhang, Da Chun Chen, Mei Hong Xiu, Fan Wang, Ling Yan Qi, Hong Qiang Sun, Song Chen, Shu Chang He, Gui Ying Wu, Colin N. Haile et al. · 2009 · Schizophrenia Research
7. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains
   P. J. Norris, Richard L. M. Faull, Piers C. Emson · 1996 · Molecular Brain Research
8. Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia
   Jeffrey K. Yao, George G. Dougherty, Ravinder D Reddy, Matcheri S. Keshavan, Debra M. Montrose, Wayne R. Matson, Joseph P. McEvoy, Rima Kaddurah‐Daouk · 2010 · PLoS ONE
9. Measurement of Cytokines in Clinical Samples Using Immunoassays: Problems and Pitfalls
   Rosamonde Elizabeth Banks · 2000 · Critical Reviews in Clinical Laboratory Sciences
10. Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing
    Doris Blum-Degen, Thoralf Heinemann, Jing Quan Lan, Vera Pedersen, Fritz Leblhuber, Werner Paulus, Peter Franz Riederer, Manfred Gerlach · 1999 · Brain Research
11. Negative Association Between Schizophrenia and Rheumatoid Arthritis
    Sophia Vinogradov, Irving I. Gottesman, Hans W. Moises, Susan E. Nicol · 1991 · Schizophrenia Bulletin
12. Vitamin C status in chronic schizophrenia
    Kornelia Subotičanec, Vera Folnegović-Šmalc, M Korbar, B. Mestrovic, Ratko Buzina · 1990 · Biological Psychiatry
13. Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms
    Xiangyang Zhang, Dong Feng Zhou, Lian Yuan Cao, Pei Yan Zhang, Gui Ying Wu · 2003 · Psychiatry Research
14. Cerebral laterality, symptoms, and diagnosis in psychotic patients
    Bruce E. Wexler, Earl L. Giller, Steven Mark Southwick · 1991 · Biological Psychiatry
15. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain
    Hajime Baba, Toshihito Suzuki, Heii Arai, Piers C. Emson · 2004 · Neuroreport
16. Disrupted Antioxidant Enzyme Activity and Elevated Lipid Peroxidation Products in Schizophrenic Patients With Tardive Dyskinesia
    Xiangyang Zhang, Yun Long Tan, Dong Feng Zhou, Lian Yuan Cao, Gui Ying Wu, Colin N. Haile, Therese A. Kosten, Thomas R. Kosten · 2007 · The Journal of Clinical Psychiatry
17. Human plasma glutathione peroxidase and symptom severity in schizophrenia
    JEFFREY K. YAO, Ravinder D Reddy, Daniël P. van Kammen · 1999 · Biological Psychiatry
18. Red blood cell nitric oxide levels in patients with schizophrenia
    Hasan Herken, Efkan Uz, Hüseyın Özyurt, Ömer Akyol · 2001 · Schizophrenia Research
19. Ascorbic Acid Distribution Patterns in Human Brain
    Arvin F. Oke, Leslie J. May, Ralph Norman Adams · 1987 · Annals of the New York Academy of Sciences
20. n-3 versus n-6 polyunsaturated fatty acids in critical illness
    Tsuguhiko Tashiro, Hideo Yamamori, Kazuya Takagi, Naganori Hayashi, Katsunori Furukawa, Nobuyuki Nakajima · 1998 · Nutrition
21. N‐acetylserotonin is a better extra‐ and intracellular antioxidant than melatonin
    Albert Wölfler, Peter Michael Abuja, Konrad Schauenstein, Peter M. Liebmann · 1999 · FEBS Letters
22. The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia
    S. Salih Zoroğlu, Hasan Herken, Muhittin Yürekli, Efkan Uz, Hamdi Tutkun, HALUK ASUMAN SAVAS, Cahit Bağcı, Murat Eren Özen, Beyhan Cengiz, Ecir Ali Çakmak et al. · 2002 · Journal of Psychiatric Research
23. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: Relation to psychosocial variables
    Trent D. Buckman, Arthur S. Kling, Mary S. Sutphin, Allen Steinberg, Samuel Eiduson · 1990 · Psychiatry Research
24. NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson's disease putamen
    Raik Böckelmann, Gerald L Wolf, Gerhard N. Ransmayr, Peter Franz Riederer · 1994 · Journal of Neural Transmission - Parkinsons Disease and Dementia Section
25. Potential Effect of Olanzapine on Total Antioxidant Status and Lipid Peroxidation in Schizophrenic Patients
    Basil M. Al-chalabi, Imad A. J. Thanoon, Faris A. Ahmed · 2009 · Neuropsychobiology
26. Purine Catabolism: Links to Mitochondrial Respiration and Antioxidant Defenses?
    Bruce S. Kristal, Karen E. Vigneau-Callahan, Alison J. Moskowitz, Wayne R. Matson · 1999 · Archives of Biochemistry and Biophysics
27. A Defect in the Antioxidant Defense System in Schizophrenia
    Osman Vırıt, Abdurrahman Altındağ, Mehmet Yumru, Alican Dalkiliç, HALUK ASUMAN SAVAS, Şahabettin Selek, Özcan Erel, Hasan Herken · 2009 · Neuropsychobiology
28. Acute phase proteins in male Chinese schizophrenic patients in Singapore
    Wong Chong-Thim, Wing Foo Tsoi, Nilmani Saha · 1996 · Schizophrenia Research
29. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders
    Tsuyoshi Miyaoka, Rei Yasukawa, Hideaki YASUDA, Maiko Shimizu, Soichi Mizuno, Tsuruhei Sukegawa, Takuji Inagaki, Jun Horiguchi · 2005 · European Neuropsychopharmacology
30. Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls
    Bun-Hee Lee, Yong‐Ku Kim · 2008 · Schizophrenia Research
31. Schizophrenia-Associated Idiopathic Unconjugated Hyperbilirubinemia (Gilbert's Syndrome)
    Tsuyoshi Miyaoka, Haruo Seno, Motoi Itoga, Masaaki Iijima, Takuji Inagaki, Jun Horiguchi · 2000 · The Journal of Clinical Psychiatry
32. Isoprostenes as indicators of oxidative stress in schizophrenia
    Anna Dietrich‐Muszalska, Beata Olas · 2008 · The World Journal of Biological Psychiatry
33. Telomerase levels in schizophrenia: A preliminary study
    Barbara Porton, L. E. DeLisi, Hilary C. Bertisch, Fei Ji, Derek Gordon, P LI, Melissa M. Benedict, William M. Greenberg, Hung‐Teh Kao · 2008 · Schizophrenia Research
34. Membrane Phospholipids and Cytokine Interaction in Schizophrenia
    Jeffrey K Yao, Daniël P. van Kammen · 2004 · International review of neurobiology
35. The plasma redox state and ageing
    Wulf Dröge · 2002 · Ageing Research Reviews
36. Aging and Disease: Extending Functional Life Span
    Denham Harman · 1996 · Annals of the New York Academy of Sciences
37. Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia
    Keith W. Brown, Alan W. Reid, Thomas G. White, Thomas Henderson, Sarah Hukin, Caroline Johnstone, Alastair C. A. Glen · 1998 · Biological Psychiatry
38. Immunity and schizophrenia: Autoimmunity, cytokines, and immune responses
    Fiona Gaughran · 2002 · International review of neurobiology
39. Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia
    Fatma Taneli, Şebnem Pırıldar, Fisun Akdeniz, Bekir Sami Uyanık, Zeki Arı · 2004 · Archives of Medical Research
40. Nicotine Dependence, Symptoms and Oxidative Stress in Male Patients with Schizophrenia
    Xiangyang Zhang, Yun Long Tan, Dong Feng Zhou, Colin N. Haile, Gui Ying Wu, Lian Yuan Cao, Therese A. Kosten, Thomas R. Kosten · 2007 · Neuropsychopharmacology
41. High-Performance Liquid Chromatography Separations Coupled With Coulometric Electrode Array Detectors
    Bruce S. Kristal, Yevgeniya I. Shurubor, Rima F Kaddurah-Daouk, Wayne R. Matson · 2007 · Methods in molecular biology
42. Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan
    Hisanobu Kaiya, David F. Horrobin, M.S. Manku, N. M. Fisher · 1991 · Biological Psychiatry
43. Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients
    Čedo Miljević, Milan R. Nikolic, Aleksandra Nikolić‐Kokić, David R. Jones, Vesna Niketić, Dušica Lečić‐Toševski, Mihajlo B. Spasić · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
44. Phosphorus magnetic resonance spectroscopy in schizophrenia: Correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms
    Hiroshi Fukuzako, Tsuyoshi Fukuzako, Kouzou Takeuchi, Yoshihiko Ohbo, Kenichi Ueyama, Morikuni Takigawa, Toshiro Fujimoto · 1996 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
45. Decreased Plasma Antioxidants in Schizophrenia
    Chi‐Un Pae, In‐Ho Paik, Chul Lee, Soo-Jung Lee, Jung-Jin Kim, Chang‐Uk Lee · 2004 · Neuropsychobiology
46. Coincidence of Schizophrenia and Hyperbilirubinemia
    Norbert Müller, Peter W. Schiller, Manfred Ackenheil · 1991 · Pharmacopsychiatry
47. Free Radicals in Brain Physiology and Disorders
    Larry W. Oberley · 1997 · Journal of Neuropathology & Experimental Neurology
48. Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients
    Anvita A. Kale, Sadhana Joshi, Nilesh Mahadeo Naphade, Swati Sapkale, M.S.V.K. Raju, Anilkumar Pillai, Henry A. Nasrallah, Sahebarao P. Mahadik · 2007 · Schizophrenia Research
49. Total antioxidant response in patients with schizophrenia
    Bilal Üstündağ, Murad Atmaca, OZLEM KIRTAS, Şahabettin Selek, Kerem Metin, Ertan Tezcan · 2006 · Psychiatry and Clinical Neurosciences
50. Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia
    Eiji Suzuki, Toshio Nakaki, Makoto Nakamura, Hitoshi Miyaoka · 2003 · Journal of Psychiatry and Neuroscience
51. Secondary degeneration reduced by inosine after spinal cord injury in rats
    Fei Liu, S-W You, L-P Yao, H-L Liu, X-Y Jiao, M Shi, Q-B Zhao, Gong Ju · 2005 · Spinal Cord
52. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia
    Erik Messamore · 2003 · Prostaglandins Leukotrienes and Essential Fatty Acids
53. Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia
    Jeffrey K. Yao, Daniël P. van Kammen, John A. Gurklis · 1996 · Psychiatry Research
54. Regulation of interleukin 2 production, interleukin 2 mRNA expression and intracellular glutathione levels in ex vivo derived T lymphocytes by lactate
    Steffen Roth, Wulf Dröge · 1991 · European Journal of Immunology
55. Increased turnover of platelet phosphatidylinositol in schizophrenia
    J.K. Yao, P. Yasaei, Daniël P. van Kammen · 1992 · Prostaglandins Leukotrienes and Essential Fatty Acids
56. Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus.
    Hans-Gert Bernstein, Arndt Heinemann, Dieter Krell, Hendrik Dobrowolny, Hendrik Bielau, Gerburg Keilhoff, Bernhard Bogerts · 2005 · PubMed
57. The platelet polyphosphoinositide system in Schizophrenia: The effects of neuroleptic treatment
    M.A. Essali, Indrajit Das, Jacqueline de Belleroche, Steven R. Hirsch · 1990 · Biological Psychiatry
58. Membrane Damage from Lipid Oxidation Induced by Free Radicals and Cigarette Smokea
    Etsuo Niki, Susumu Minamisawa, Miyuki Oikawa, Erika Komuro · 1993 · Annals of the New York Academy of Sciences
59. Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study
    Yuichiro Nakano, Reiji Yoshimura, Hideki Nakano, Atsuko Ikenouchi, Hikaru Hori, Wakako Umene‐Nakano, Nobuhisa Ueda, Jun Nakamura · 2010 · Human Psychopharmacology Clinical and Experimental
60. Accumulation of diacylgylcerol in platelet phosphoinositide turnover in Schizophrenia: A biological marker of good prognosis?
    Hisanobu Kaiya, Akira Nishida, Atsushi Imai, Shigeru Nakashima, Yoshinori Nozawa · 1989 · Biological Psychiatry
61. Protein Deficiency, Starvation and Protein Metabolism
    D. J. Millward · 1979 · Proceedings of The Nutrition Society
62. Niacin sensitivity and the arachidonic acid pathway in schizophrenia
    Erik Messamore, William F. Hoffman, JEFFREY K. YAO · 2010 · Schizophrenia Research
63. Antioxidant Therapeutics for Schizophrenia
    Ravinder D Reddy, Rajiv Reddy · 2010 · Antioxidants and Redox Signaling
64. Serum uric acid levels in optic neuritis
    Christopher M. Knapp, Cris S. Constantinescu, J HY Tan, Rebecca Jane McLean, G.R. Cherryman, Irène Gottlob · 2004 · Multiple Sclerosis Journal
65. Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia
    2000 · The British Journal of Psychiatry
66. Modifications of blood platelet proteins of patients with schizophrenia
    Anna Dietrich‐Muszalska, Beata Olas · 2009 · Platelets
67. Association study between the genetic polymorphisms of glutathione‐related enzymes and schizophrenia in a Japanese population
    Daisuke Matsuzawa, Kenji Hashimoto, Tasuku Hashimoto, Eiji Shimizu, Hiroyuki Watanabe, Yūkō Fujita, Masaomi Iyo · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
68. [13] Effect of reactive oxygen intermediates and antioxidants on proliferation and function of T lymphocytes
    Wulf Dröge, Sabine Mihm, Michael Bockstette, Steffen Roth · 1994 · Methods in enzymology on CD-ROM/Methods in enzymology
69. Increased frequency of CD8 positive gamma/delta T-lymphocytes (CD8+γ/δ+) in unmedicated schizophrenic patients: relation to impairment of the blood–brain barrier and HLA-DPA*02011
    Norbert Müller, Barbara C. Schlesinger, M. Hadjamu, Michael J Riedel, Markus Schwarz, Manfred Ackenheil, R. Wank, Rudolf Gruber · 1998 · Schizophrenia Research
70. BRIEF COMMUNICATION Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia
    Kei Yamada, Susumu Kanba, Sachiko Anamizu, K. OHNISHI, Iyoko Ashikari, Gohei Yagi, Masashi Asai · 1997 · Psychological Medicine
71. Monitoring oxidative and nitrative modification of cellular proteins; a paradigm for identifying key disease related markers of oxidative stress
    James M. Murray, C. Elisa Oquendo, John H. Willis, Michael F. Marusich, Roderick Capaldi · 2008 · Advanced Drug Delivery Reviews
72. Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat
    Taylor A Seaton, Peter G. Jenner, C. DAVID MARSDEN · 1996 · Biochemical Pharmacology
73. Metabolic Investigation in Psychiatric Disorders
    Yao, Jeffrey K., Reddy, Ravinder D. · 2005 · Molecular Neurobiology
74. Serum bilirubin levels and UGT1A1 promoter variations in patients with schizophrenia
    Libor Vı́tek, Michaela Novotná, Martin Lenicek A, Ladislav Novotný, Jitka Eberová, Jan Petrášek, Milan Jirsa · 2010 · Psychiatry Research
75. Nitric oxide in the pathogenesis of Parkinson's disease.
    M. Gerlach, Doris Blum-Degen, Jing Quan Lan, Peter Franz Riederer · 1999 · PubMed
76. A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.
    P. Steullet, S. Lavoie, R. Kraftsik, Raffaella Guidi, R. Gysin, M. Cuenod, K. Do · 2008 · Free Radical Biology & Medicine
77. Oxidative stress and superoxide dismutase in schizophrenia
    Nusrat Khan, Indrajit Das · 1997 · Biochemical Society Transactions
78. Serum thiobarbituric acid-reactive substances and free thiol levels in schizophrenia patients: Effects of antipsychotic drugs
    Tiao‐Lai Huang, Chia‐Wei Liou, Tsu‐Kung Lin · 2010 · Psychiatry Research
79. Environmental factors and membrane polyunsaturated fatty acids in schizophrenia
    Ravinder D Reddy, Jeffrey K Yao · 2003 · Prostaglandins Leukotrienes and Essential Fatty Acids
80. Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia
    Philippe Nuss, Cédric Tessier, Florian Ferreri, Marc D. Binder, Joseph Peuskens, Germain Trugnan, Joëlle Masliah, Claude Wolf · 2009 · Psychiatry Research
81. Megavitamin and Dietary Treatment in Schizophrenia: A Randomised, Controlled Trial
    Kevin Vaughan, Nathaniel McConaghy · 1999 · Australian & New Zealand Journal of Psychiatry
82. Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study
    Koichi Nisijima, Takeo Ishiguro · 1993 · Biological Psychiatry
83. Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia
    Andrew O. Skinner, Sahebarao P. Mahadik, David L. Garver · 2004 · Schizophrenia Research
84. Increased concentrations of phosphatidylinositol (PI) and decreased esterification of arachidonic acid into phospholipids in platelets from patients with schizoaffective disorders or atypic phasic psychoses
    L. Demisch, K. Heinz, Hector Gerbaldo, R. Kirsten · 1992 · Prostaglandins Leukotrienes and Essential Fatty Acids
85. [Lipid peroxidation processes in patients with schizophrenia].
    E S Kovaleva, O N Orlov, M Ia Tsutsu'lkovskaia, Vladimirova Tv, Beliaev Bs · 1989 · PubMed
86. Schizophrenia and Rheumatoid Arthritis
    Graham W Mellsop · 1972 · Australian & New Zealand Journal of Psychiatry
87. Protective effect of N‐acetyl‐serotonin on the nonenzymatic lipid peroxidation in rat testicular microsomes and mitochondria
    Mariana Gavazza, Ángel Catalá · 2004 · Journal of Pineal Research
88. Application of [3H]l-NG-nitro-arginine labelling to measure cerebellar nitric oxide synthase in patients with schizophrenia
    Christopher A. Doyle, P. Slater · 1995 · Neuroscience Letters
89. Determination of multiple redox-active compounds by high-performance liquid chromatography with coulometric multi-electrode array system
    JEFFREY K. YAO, Po-Hung Cheng · 2004 · Journal of Chromatography B
90. [Analysis of platelet superoxide dismutase 1 in the development of childhood psychoses].
    Bernard Golse, P Debray-Ritzen, Krystyna Puget, A. Michael Michelson · 1977 · PubMed
91. [Indices of lipid free-radical oxidation and of antiradical protection of the brain--the neurochemical correlates of the development of the general adaptation syndrome].
    Guliaeva Nv, I P Levshina, A B Obidin · 1988 · PubMed
92. The Possible Role of Lipid Peroxidation in the Pathophysiology of Mental Disorders
    Leonid L. Prilipko · 1992 · Springer eBooks
93. Reduced status of plasma total antioxidant capacity in schizophrenia with tardive dyskinesia
    Da Chun Chen, Mei Hong Xiu, Hong Liu, Ben Shu Zhang, Yu Wang, Thomas R. Kosten, Xiangyang Zhang · 2010 · Journal of Psychiatric Research
94. Elevated plasma lipid peroxides in schizophrenic patients without dementia
    Denise R. Evans, P.Y. Puczkowski, M.J. Brandsma, J. Mahadik, Sahebarao P. Mahadik · 1996 · Biological Psychiatry
95. Ascorbate
    George V. Rebec · 1997 · Springer eBooks
96. [Lipid peroxidation processes as one of the factors modifying neuronal membrane-bound proteins in schizophrenia].
    Prilipko Ll, Lideman Rr · 1982 · PubMed